MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào)，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。

CAS No. : 956906-93-7

MCE 國(guó)際站：PF-04217903 methanesulfonate

產(chǎn)品活性：PF-04217903 methanesulfonate 是一種高效的ATP競(jìng)爭(zhēng)性 c-Met 激酶抑制劑，K_i 為 4.8 nM。PF-04217903 methanesulfonate 相對(duì)于 208 個(gè)激酶顯示出 1000 倍以上的選擇性。具有抗血管生成特性。

研究領(lǐng)域：Protein Tyrosine Kinase/RTK

作用靶點(diǎn)：c-Met/HGFR

In Vitro: PF-04217903 methanesulfonate (0.1-10000 nM; 48-72 hours) inhibits proliferation of c-Met–amplified human GTL-16 gastric carcinoma and H1993 NSCLC cells with IC₅₀ values of 12 and 30 nM, respectively.
PF-04217903 induces apoptosis of GTL-16 cells (IC₅₀=31 nM) .
PF-04217903 methanesulfonate also inhibits HGF-mediated cell migration and Matrigel invasion in several c-Met–overexpressing tumor cell lines such as human NCI-H441 lung carcinoma and HT29 colon carcinoma with IC50 values comparable with those for inhibition of c-Met phosphorylation in these cell lines (IC₅₀= 7-12.5 nM).
PF-04217903 methanesulfonate displays similar potency to inhibit the activity of c-Met-H1094R, c-Met-R988C, and c-Met-T1010I with IC₅₀ of 3.1 nM, 6.4 nM, and 6.7 nM, respectively, but has no inhibitory activity against c-Met-Y1230C with IC₅₀ of >10 μM.

In Vivo: PF-04217903 methanesulfonate (1-30 mg/kg; p.o.; daily for 16 days) shows dose-dependent tumor growth inhibition, which correlated with the inhibition in c-Met phosphorylation in these tumors .
PF-04217903 methanesulfonate (5-50 mg/kg, p.o.; once daily for 3 days) dose dependently inhibits c-Met, Gab-1, Erk1/2, and AKT phosphorylation and induced apoptosis (cleaved caspase-3) in U87MG xenograft tumors at all dose levels. PF-04217903 methanesulfonate shows a significant dose-dependent reduction of human IL-8 levels in both the U87MG and GTL-16 models and decreases human VEGFA levels in the GTL-16 model. PF-04217903 methanesulfonate strongly induces phospho-PDGFRβ levels in U87MG xenograft tumors.

相關(guān)產(chǎn)品：Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Kinase Inhibitor Library  |  Protein Tyrosine Kinase Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Anti-Lung Cancer Compound Library  |  PHA-665752  |  2-Phospho-L-ascorbic acid trisodium  |  SU11274  |  SRI 31215 TFA  |  c-Met inhibitor 1  |  X-376  |  Tyrosine kinase inhibitor  |  c-met-IN-1  |  Meleagrin  |  Norleual  |  Ensartinib

品牌介紹:
•   MCE (MedChemExpress) 擁有數(shù)百種全球獨(dú)家化合物，我們致力于為全球科研客戶提供最新最全的高品質(zhì)小分子活性化合物；
•   10,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門(mén)信號(hào)通路及疾病領(lǐng)域；
•   設(shè)有專(zhuān)業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告，確保產(chǎn)品的高純度、高品質(zhì)；
•   產(chǎn)品的生物活性多經(jīng)各國(guó)客戶實(shí)驗(yàn)驗(yàn)證；
•   Nature, Cell, Science 等多種頂級(jí)期刊及制藥專(zhuān)利收錄了MCE客戶的科研成果；
•   專(zhuān)業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展，為您提供全球最新的活性化合物；
•   與世界各大制藥公司及知名科研機(jī)構(gòu)建立了長(zhǎng)期的合作。